Akshay Vaishnaw, MD, PhD

Director

Dr. Akshay Vaishnaw is the President of Research and Development (R&D) at Scholar Rock. He also serves on the Board of Directors at Scholar Rock, Editas Medicine, and is a Venture Partner at Atlas Venture. Previously, Dr. Vaishnaw was Chief Innovation Officer and President of Alnylam Pharmaceuticals, where he held positions of increasing responsibility across Research and Development since joining the company in 2006.  Dr. Vaishnaw earned his bachelor’s degree from University College Cardiff, his MD from the University of Wales College of Medicine, and his PhD in Molecular Immunology from the University of London.

Meet the Team

Hemab unites experts in clotting, patient care, and drug development to transform the lives of people with bleeding disorders

Leadership
Board
Team
Investors
Access Biotechnology
Avoro Ventures
Deep Track Capital
HealthCap
Invus
Maj Invest Equity
Novo Holdings
RA Capital
Rock Springs Capital
Sofinnova Partners
Hemab team photo
Hemab icon in larger circles

We’re building the ultimate clotting company.